CTKB
Cytek Biosciences Inc
NASDAQ: CTKB · HEALTHCARE · MEDICAL DEVICES
$4.56
+2.70% today
Updated 2026-04-30
Market cap
$565.62M
P/E ratio
—
P/S ratio
2.81x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$2 – $6
Volume
0.7M
Cytek Biosciences Inc (CTKB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-33.00%
Operating margin
-9.00%
ROE
-18.00%
ROA
-5.25%
Debt/equity
0.09x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $57.88M | $-16.83M | 49.54% | -29.81% | -29.07% |
| 2020 | $92.84M | $19.41M | 55.70% | 14.71% | 20.91% |
| 2021 | $127.95M | $3.00M | 61.86% | 7.16% | 2.35% |
| 2022 | $164.04M | $2.58M | 61.56% | -1.10% | 1.57% |
| 2023 | $193.01M | $-12.15M | 56.69% | -14.43% | -6.29% |
| 2024 | $200.45M | $-6.02M | 55.43% | -10.24% | -3.00% |
| 2025 | $201.49M | $-66.54M | 51.84% | -20.04% | -33.02% |